Illumina Wants 'Entirely Derivative' Antitrust Suit Paused
Illumina wants a California federal judge to pause a competitor's antitrust suit so the gene-sequencing behemoth can first pursue its patent infringement suit against that same rival....To view the full article, register now.
Already a subscriber? Click here to view full article